RxDoctor Payments DataLook up a doctor →

Anuj Jayakar

Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1609125905

Payments from drug & device makers

$360,604in general payments, 2019–2025

Across 545 payments — averaging $661.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB SA$309K
  • Immedica Pharma US, Inc.$18K
  • Neurelis, Inc.$11K
  • UCB Biosciences Inc.$10K
  • UCB, Inc.$4K
  • Jazz Pharmaceuticals Inc.$3K
  • plus $6K from 33 others
$820in research payments, 2019–2025

Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB, Inc.$820

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB SA17$309,421
Immedica Pharma US, Inc.20$17,598
Neurelis, Inc.105$10,868
UCB Biosciences Inc.1$10,000
UCB, Inc.103$4,295
Jazz Pharmaceuticals Inc.84$2,697
Sunovion Pharmaceuticals Inc.26$2,051
Aquestive Therapeutics, Inc.30$530
Eisai Inc.34$443
Sumitomo Pharma America, Inc.13$323
Corium, LLC17$304
Livanova USA, Inc.15$300
Ironshore Pharmaceuticals Inc.13$192
Biogen7$159
Biocodex, Inc.5$157
Zogenix Inc.5$140
Kyowa Kirin, Inc.1$137
SK Life Science, Inc.6$125
Catalyst Pharmaceuticals, Inc.6$112
Aprecia Pharmaceuticals, LLC6$90
Azurity Pharmaceuticals, Inc.4$88
Biomarin Pharmaceutical Inc.1$69
Novartis4$61
NS Pharma, Inc.3$48
Aucta Pharmaceuticals, Inc.2$46
Upsher-smith Laboratories LLC2$46
AbbVie2$45
Supernus Pharmaceuticals, Inc.2$34
Sarepta Therapeutics, Inc.1$29
Acadia Pharmaceuticals Inc1$26
Greenwich Biosciences, Inc.1$25
AstraZeneca1$24
Merz Pharmaceuticals, LLC1$21
ITF Therapeutics LLC1$21
Saol Therapeutics Inc.1$19
Tris Pharma Inc1$18
Mallinckrodt Enterprises LLC1$17
Piramal Critical Care1$13
Takeda Pharmaceuticals U.S.A., Inc.1$13

How this compares

$360,604 in reported general payments places this provider in the 90th percentile of 137 neurology with special qualifications in child neurology providers in Florida.

See all neurology with special qualifications in child neurology providers in Florida →

Other neurology with special qualifications in child neurology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →